Related topic: Remicade, Extravasation
Review: could Remicade cause Extravasation?
Summary: Extravasation could be caused by Remicade, especially for people who are female, 60+ old, have been taking the drug for < 1 month, also take Methotrexate, and have Rheumatoid arthritis.
We study 85,034 people who have side effects while taking Remicade from FDA and social media. Among them, 20 have Extravasation. Find out below who they are, when they have Extravasation and more.
How are my drugs for patients like me? On eHealthMe, you can find the answer by studying 348 million drug outcomes from FDA and social media. Start now >>>
Remicade (latest outcomes from 85,433 users) has active ingredients of infliximab. It is often used in crohn's disease.
Extravasation (leakage of a fluid) (latest reports from 4,366 patients) has been reported by people with breast cancer, computerised tomogram abnormal, colon cancer, osteoporosis, multiple sclerosis.
On Apr, 15, 2014: 85,034 people reported to have side effects when taking Remicade. Among them, 20 people (0.02%) have Extravasation. They amount to 0.46% of all the 4,363 people who have Extravasation on eHealthMe.
Time on Remicade when people have Extravasation * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
Gender of people who have Extravasation when taking Remicade * :
Age of people who have Extravasation when taking Remicade * :
Severity of Extravasation when taking Remicade ** :
How people recovered from Extravasation ** :
Top conditions involved for these people * :
- Rheumatoid arthritis (12 people, 60.00%)
- Crohn's disease (6 people, 30.00%)
- Colitis ulcerative (4 people, 20.00%)
- Psoriatic arthropathy (2 people, 10.00%)
- Immunosuppression (1 people, 5.00%)
Top co-used drugs for these people * :
- Methotrexate (19 people, 95.00%)
- Prednisone (16 people, 80.00%)
- Folic acid (16 people, 80.00%)
- Diflucan (12 people, 60.00%)
- Acetaminophen (11 people, 55.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
You can also:
On eHealthMe, Remicade (infliximab) is often used for crohn's disease. Find out below the conditions Remicade is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Remicade used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
Comments from related studies:
From this study (1 month ago):
Sporadic hot irritating flushing at random times. Sometimes painfull
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Remicade, Extravasation
More reviews for: Remicade, Extravasation
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.